Niger has observed a 6% (23.1%) increase in the pregnant women living with hiv antiretroviral therapy coverage for pmtct, which now stands at 32%.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in Niger
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,760
Measure:
%
Similar regions to Niger
PMTCT antiretroviral therapy coverage
More indicators for Niger
Male unintentional poisoning
4.0
-0.1
(2019)
Female wasting in children
9.7%
-0.9%
(2022)
Female prevalence of HIV
0.1%
0%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar32
-intl dollar2
(2021)
Birth registration
63.9%
+32.1%
(2012)
Contraceptive modern method prevalence
10%
-0.5%
(2021)
Niger PMTCT antiretroviral therapy coverage between 2000 and 2022
| Period | PMTCT antiretroviral therapy coverage | Change |
|---|---|---|
| 2022 | 32% | +6% |
| 2021 | 26% | -1% |
| 2020 | 27% | -7% |
| 2019 | 34% | -6% |
| 2018 | 40% | -2% |
| 2017 | 42% | -24% |
| 2016 | 66% | +25% |
| 2015 | 41% | -21% |
| 2014 | 62% | +10% |
| 2013 | 52% | -1% |
| 2012 | 53% | -7% |
| 2011 | 60% | -19% |
| 2010 | 79% | +58% |
| 2009 | 21% | +9% |
| 2008 | 12% | +7% |
| 2007 | 5% | +3% |
| 2006 | 2% | +1% |
| 2005 | 1% | -2% |
| 2004 | 3% | +3% |
| 2003 | 0% | 0% |
| 2002 | 0% | 0% |
| 2001 | 0% | 0% |
| 2000 | 0% |